Resson
A bioinformatics and predictive analytics company.
Launch date
Market cap
-
Enterprise valuation
€51—76m (Dealroom.co estimates May 2018.)
Fredericton New Brunswick (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.0m | Series A | ||
$11.0m | Series B | ||
$14.0m | Series C | ||
Total Funding | €25.5m |
Related Content
Recent News about Resson
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.